Sclerostin and cardiovascular disease

JH Tobias - Current osteoporosis reports, 2023 - Springer
Abstract Purpose of Review The role of wnt signalling in atherogenesis raises the possibility
that the wnt inhibitor, sclerostin, provides a natural defence to this process, and that anti …

[HTML][HTML] Integrative single-cell meta-analysis reveals disease-relevant vascular cell states and markers in human atherosclerosis

JV Mosquera, G Auguste, D Wong, AW Turner… - Cell Reports, 2023 - cell.com
Coronary artery disease (CAD) is characterized by atherosclerotic plaque formation in the
arterial wall. CAD progression involves complex interactions and phenotypic plasticity …

[HTML][HTML] Beyond the Basics: Unraveling the Complexity of Coronary Artery Calcification

S Hashmi, PW Shah, Z Aherrahrou, E Aikawa… - Cells, 2023 - mdpi.com
Coronary artery calcification (CAC) is mainly associated with coronary atherosclerosis,
which is an indicator of coronary artery disease (CAD). CAC refers to the accumulation of …

Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: evidence from a genome‐wide association meta‐analysis followed by …

J Zheng, E Wheeler, M Pietzner… - Arthritis & …, 2023 - Wiley Online Library
Objective In this study, we aimed to establish the causal effects of lowering sclerostin, target
of the antiosteoporosis drug romosozumab, on atherosclerosis and its risk factors. Methods …

Adenosine kinase inhibition protects mice from abdominal aortic aneurysm via epigenetic modulation of VSMC inflammation

J Xu, Z Liu, Q Yang, Q Ma, Y Zhou, Y Cai… - Cardiovascular …, 2024 - academic.oup.com
Aims Abdominal aortic aneurysm (AAA) is a common, serious vascular disease with no
effective pharmacological treatment. The nucleoside adenosine plays an important role in …

Unraveling interindividual variation of trimethylamine N‐oxide and its precursors at the population level

S Andreu‐Sánchez, S Ahmad, A Kurilshikov… - Imeta, 2024 - Wiley Online Library
Trimethylamine N‐oxide (TMAO) is a circulating microbiome‐derived metabolite implicated
in the development of atherosclerosis and cardiovascular disease (CVD). We investigated …

Mineral stress drives loss of heterochromatin: an early harbinger of vascular inflammaging and calcification

CY Ho, MY Wu, J Thammaphet, S Ahmad… - Circulation …, 2025 - ahajournals.org
BACKGROUND: Vascular calcification is a detrimental aging pathology markedly
accelerated in patients with chronic kidney disease. PLA (prelamin A) is a biomarker of …

[HTML][HTML] Multi-ancestry genetic analysis of gene regulation in coronary arteries prioritizes disease risk loci

CJ Hodonsky, AW Turner, MD Khan, NB Barrientos… - Cell genomics, 2024 - cell.com
Genome-wide association studies (GWASs) have identified hundreds of risk loci for coronary
artery disease (CAD). However, non-European populations are underrepresented in …

The association between non-alcoholic liver fatty disease and coronary artery calcification: a two-sample Mendelian randomization study

L He, X Tiemuerniyazi, Z Yang, S Huang… - European Journal of …, 2024 - academic.oup.com
Aims Although prior observational studies have suggested that patients with non-alcoholic
fatty liver disease (NAFLD) may have a higher risk of coronary artery calcification (CAC) …

Type 2 diabetes modifies the association of CAD genomic risk variants with subclinical atherosclerosis

NR Hasbani, KE Westerman, SH Kwak… - Circulation: Genomic …, 2023 - ahajournals.org
BACKGROUND: Individuals with type 2 diabetes (T2D) have an increased risk of coronary
artery disease (CAD), but questions remain about the underlying pathology. Identifying …